Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

NCT00156962 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
850
Enrollment
INDUSTRY
Sponsor class

Stopped Regulatory decision not to proceed

Conditions

Interventions

Sponsor

Amgen